Cord blood is the stated source material for Bio Xsomes, which the supplier describes as derived through a progenitor endothelial cell line (hPESC) rather than from whole blood directly. Request source documentation confirming this pathway for the specific lot.
Cord blood is also widely collected for public and private banking programs, a separate chain of custody from cord blood collected for manufacturing. Supplier donor materials state that donating cord blood for manufacturing purposes does not affect a mother's separate option to bank cord blood.
Buyers evaluating a cord blood-derived exosome product should ask the supplier to identify the specific source cell population used and to provide characterization data, such as ELISA, nanoparticle tracking analysis or tetraspanin marker results, rather than relying on the phrase 'cord blood-derived' alone as a specification.
The phrase 'cord blood-derived' describes a starting material, not a finished-product specification, so clinics need the source cell and characterization details behind any exosome product in this category.